School of Computer and Information Science, Hunan Institute of Technology, Hengyang, China.
School of Economics and Statistics, Guangzhou University, Guangzhou, China.
Front Public Health. 2021 Apr 29;9:647357. doi: 10.3389/fpubh.2021.647357. eCollection 2021.
By taking 22 OECD countries from 2010 to 2017 as sample, we study the effect of pharmaceutical manufacturing innovation on perceived health by using the panel Tobit model from the entire sample and sub-samples, respectively, as well as analyze their transmission channels by adding moderating effect. Based on the above, we get the following results: first, the pharmaceutical manufacturing innovation 4 years ago has a positive influence on perceived health, which means the improvement of perceived health is closely related to pharmaceutical manufacturing innovation 4 years ago. Second, pharmaceutical manufacturing innovation has a heterogeneous impact on perceived health, which, including the size and direction of the impact effect, is mainly reflected in different pharmaceutical manufacturing innovation levels, population aging degrees, and education levels. Third, income level can positively regulate the impact of pharmaceutical manufacturing innovation on perceived health.
以 2010 年至 2017 年的 22 个经合组织国家为样本,我们分别使用全样本和子样本的面板 Tobit 模型研究了制药制造业创新对感知健康的影响,并通过加入调节效应分析了它们的传递渠道。在此基础上,我们得出以下结论:第一,4 年前的制药制造业创新对感知健康有正向影响,这意味着感知健康的改善与 4 年前的制药制造业创新密切相关。第二,制药制造业创新对感知健康的影响具有异质性,包括影响效应的大小和方向,主要体现在不同的制药制造业创新水平、人口老龄化程度和教育水平上。第三,收入水平可以正向调节制药制造业创新对感知健康的影响。